Private equity firm Silver Lake is in exclusive talks to acquire a majority stake in Intel’s (NASDAQ: INTC) programmable chip business, Altera, for about $9 billion, according to sources familiar with the matter. The deal, still being finalized, could face delays, and the exact stake size remains undetermined.
Silver Lake has declined to comment, while Intel has yet to respond. Bloomberg first reported the negotiations. Previously, Reuters noted that Silver Lake and Bain Capital were among firms considering an investment in Altera, which Intel purchased for nearly $17 billion in 2015. Francisco Partners also expressed interest.
The potential deal could provide Intel with much-needed capital as it seeks to cut costs and divest non-core assets. Intel’s former CEO, Pat Gelsinger, previously indicated plans to sell a stake in Altera before a future IPO, aiming to close discussions by early 2025.
Meanwhile, Taiwan Semiconductor Manufacturing Co. and Broadcom (NASDAQ: AVGO) are reportedly exploring deals that could restructure Intel, according to The Wall Street Journal.
Intel recently posted stronger-than-expected December-quarter earnings but issued a weaker revenue outlook amid sluggish demand for data center chips. Investors are also awaiting the appointment of a new CEO.
This move aligns with Intel’s broader strategy to streamline operations and secure funding for core business growth.


Boeing Reaches Tentative Settlement With Canadian Victim’s Family in 737 MAX Crash Lawsuits
Amazon Reviews Supplier Costs as U.S.–China Tariffs Ease
Nvidia Denies Upfront Payment Requirement for H200 AI Chips Amid China Export Scrutiny
TSMC Set to Post Record Q4 Profit as AI Chip Demand Accelerates
BlueScope Steel Announces A$1 Special Dividend After Asset Sales
Trump Considers Starlink to Restore Internet Access in Iran Amid Protests
Saks Global Files for Bankruptcy Protection Amid Mounting Luxury Retail Pressures
Zhipu AI Launches GLM-Image Model Trained on Huawei Chips, Boosting China’s AI Self-Reliance Drive
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
AbbVie Commits $100 Billion to U.S. Investment in Drug Pricing Deal With Trump Administration
Trump Administration Approves Nvidia H200 AI Chip Sales to China Under New Export Rules
AFT Leaves X Over AI-Generated Images of Minors
U.S. Government Invests $1 Billion in L3Harris Rocket Motor Business to Secure Missile Supply Chain
xAI Restricts Grok Image Editing After Sexualized AI Images Trigger Global Scrutiny
Taiwan Issues Arrest Warrant for OnePlus CEO Over Alleged Illegal Recruitment Activities
Microsoft Strikes Landmark Soil Carbon Credit Deal With Indigo Carbon to Boost Carbon-Negative Goal
FCC Exempts Select Foreign-Made Drones From U.S. Import Ban Until 2026 



